Smart Inhalers Market Size & Share Report, 2032

Smart Inhalers Market - By Product (DPI-based Smart Inhalers, MDI-based Smart Inhalers), By Disease Indication (Asthma, Chronic Obstructive Pulmonary Disease), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-commerce)– Global Forecast, 2023-2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definition

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; workings

1.3&nbsp;&nbsp;&nbsp; Forecast calculations

1.4&nbsp;&nbsp;&nbsp; Data Sources

1.4.1&nbsp;&nbsp;&nbsp; Primary

1.4.2&nbsp;&nbsp;&nbsp; Secondary

1.4.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.4.2.2&nbsp;&nbsp;&nbsp;Unpaid sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Global smart inhalers market 3600&nbsp;synopsis, 2018 &ndash; 2032

2.2&nbsp;&nbsp;&nbsp; Regional trends

2.3&nbsp;&nbsp;&nbsp; Product trends

2.4&nbsp;&nbsp;&nbsp; Disease indication trends

2.5&nbsp;&nbsp;&nbsp; Distribution channel trends

Chapter 3&nbsp;&nbsp;&nbsp;Smart Inhalers Industry Insights

3.1&nbsp;&nbsp;&nbsp; COVID- 19 impact analysis

3.2&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.3&nbsp;&nbsp;&nbsp; Technology landscape

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5&nbsp;&nbsp;&nbsp; Industry impact forces

3.5.1&nbsp;&nbsp;&nbsp; Growth drivers

3.5.1.1&nbsp;&nbsp;&nbsp;Growing prevalence of respiratory diseases across the globe

3.5.1.2&nbsp;&nbsp;&nbsp;Technological advancements in smart inhalers

3.5.1.3&nbsp;&nbsp;&nbsp;Increasing number of partnership agreements between pharma and software companies

3.5.1.4&nbsp;&nbsp;&nbsp;Increased medical adherence

3.5.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.5.2.1&nbsp;&nbsp;&nbsp;Dearth of awareness in developing countries

3.5.2.2&nbsp;&nbsp;&nbsp;Significant security risks and privacy issues

3.6&nbsp;&nbsp;&nbsp; Growth potential analysis

3.6.1&nbsp;&nbsp;&nbsp; By product

3.6.2&nbsp;&nbsp;&nbsp; By disease indication

3.6.3&nbsp;&nbsp;&nbsp; By distribution channel

3.7&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.8&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.1.1&nbsp;&nbsp;&nbsp; Adherium

4.1.2&nbsp;&nbsp;&nbsp; GlaxoSmithKline Plc

4.1.3&nbsp;&nbsp;&nbsp; Novartis AG

4.2&nbsp;&nbsp;&nbsp; Competitive analysis of major market players, 2022

4.3&nbsp;&nbsp;&nbsp; Competitive positioning matrix, 2022

4.4&nbsp;&nbsp;&nbsp; Strategic outlook matrix, 2022

Chapter 5&nbsp;&nbsp;&nbsp;Smart Inhalers Market Size and Forecast, By Product, 2018-2032 (USD Million)

5.1&nbsp;&nbsp;&nbsp; Key trends, by product

5.2&nbsp;&nbsp;&nbsp; Dry powder inhaler (DPI)-based smart inhalers

5.3&nbsp;&nbsp;&nbsp; Metered dose inhaler (MDI)-based smart inhalers

Chapter 6&nbsp;&nbsp;&nbsp;Smart Inhalers Market Size and Forecast, By Disease Indication, 2018-2032 (USD Million)

6.1&nbsp;&nbsp;&nbsp; Key trends, by disease indication

6.2&nbsp;&nbsp;&nbsp; Asthma

6.3&nbsp;&nbsp;&nbsp; Chronic obstructive pulmonary diseases

Chapter 7&nbsp;&nbsp;&nbsp;Smart Inhalers Market Size and Forecast, By Distribution Channel, 2018-2032 (USD Million)

7.1&nbsp;&nbsp;&nbsp; Key trends, by distribution channel

7.2&nbsp;&nbsp;&nbsp; Hospital pharmacies

7.3&nbsp;&nbsp;&nbsp; Retail pharmacies

7.4&nbsp;&nbsp;&nbsp; E-commerce

Chapter 8&nbsp;&nbsp;&nbsp;Smart Inhalers Market Size and Forecast, By Region, 2018-2032 (USD Million)

8.1&nbsp;&nbsp;&nbsp; Key trends, by region

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Italy

8.3.5&nbsp;&nbsp;&nbsp; Spain

8.3.6&nbsp;&nbsp;&nbsp; Rest of Europe

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; China

8.4.2&nbsp;&nbsp;&nbsp; Japan

8.4.3&nbsp;&nbsp;&nbsp; India

8.4.4&nbsp;&nbsp;&nbsp; Australia

8.4.5&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

8.5&nbsp;&nbsp;&nbsp; Latin America

8.5.1&nbsp;&nbsp;&nbsp; Brazil

8.5.2&nbsp;&nbsp;&nbsp; Mexico

8.5.3&nbsp;&nbsp;&nbsp; Rest of Latin America

8.6&nbsp;&nbsp;&nbsp; Middle East &amp; Africa

8.6.1&nbsp;&nbsp;&nbsp; South Africa

8.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

8.6.3&nbsp;&nbsp;&nbsp; Turkey

8.6.4&nbsp;&nbsp;&nbsp; Rest of Middle East &amp; Africa

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; Adherium

9.2&nbsp;&nbsp;&nbsp; Propeller Health

9.3&nbsp;&nbsp;&nbsp; Nemera

9.4&nbsp;&nbsp;&nbsp; GlaxoSmithKline Plc.

9.5&nbsp;&nbsp;&nbsp; Novartis AG

9.6&nbsp;&nbsp;&nbsp; Aptar Group Inc.

9.7&nbsp;&nbsp;&nbsp; AstraZeneca Plc

9.8&nbsp;&nbsp;&nbsp; Findair Sp. Z.o.o.

9.9&nbsp;&nbsp;&nbsp; BioCorp

9.10&nbsp;&nbsp;&nbsp; Zeolr Technologies Pvt Ltd.

9.11&nbsp;&nbsp;&nbsp; Vectura Group Plc.

9.12&nbsp;&nbsp;&nbsp; Teva Pharmaceutical Industries Ltd.

9.13&nbsp;&nbsp;&nbsp; Boehringer Ingelheim International GmbH

&nbsp;&nbsp;&nbsp;

Smart Inhalers Market

Get a free sample of this report

Industries

Information

Link

Global Headquarters